"Eat"

In clinical practice, patients often say that they often catch a cold. Sometimes they catch a cold several times a day. They often take some cold medicine, sometimes it is easy to use, sometimes it is useless, and they are very distressed. I learned through careful inquiry that in fact, he had allergic rhinitis, not a cold. Now, let's introduce the difference between cold and rhinitis, so that patients can have a clear understanding of it, and don't miss the treatment.

Researchers at the Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai have now identified a new treatment that promises to help cancer patients with bone marrow transplants manage side effects better than current standard therapies, making the treatment more effective and safer.

Blood cancer is a very complicated disease and should be treated in a timely manner to improve your disease and health condition and to gradually relieve your symptoms.

Immunotherapy has been a very important treatment in recent years, with many patients in lung cancer, malignant melanoma and many other cancers experiencing dramatic improvements in prognosis with this cutting-edge therapy. In pancreatic cancer, however, progress in immunotherapy has been very slow and its effectiveness has been extremely limited.

According to Chinese medicine, the liver is mainly responsible for facilitating digestion and absorption, as well as maintaining the flow of Qi, blood and fluids. The liver is also responsible for the flow of qi, blood and fluids. The liver can cleanse the body of waste, destroy toxic substances, participate in digestion and absorption, and coordinate its mental and emotional activities.

The US FDA approved a new treatment for non-small cell lung cancer - Tremelimumab + Durvalumab + platinum-based chemotherapy. The triple combination therapy significantly improves efficacy and patient survival and has a good safety profile.

Prior to the granting of marketing authorisation by the MHRA, Biyze® had been approved by the European Commission for a number of indications and is currently the only drug approved for the treatment of MZL in Great Britain.

There is an urgent clinical need for new antimicrobial drugs to break through the dilemma of cIAI treatment in children and address the growing challenge of drug resistance.

Data from a study recently published by the Royal Marsden Cancer Centre showed promising data for the combination of Avutometinib + Defactinib in the treatment of ovarian cancer, resulting in significant tumour shrinkage in 28% of patients and disease control in 93% of patients.

Vocal cord cancer often leads to hoarseness, which is a common symptom of many diseases and can be easily overlooked by patients.